# Progress Note 07 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Alan Turing (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML007-SYN-TD
- Date: 1953-10-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rupert Hallam, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic preventive visit; no new complaints. **S**

## History of present illness

Mr. Turing is a 41-year-old mathematician who comes for his periodic preventive visit two weeks after his six-month review. He completed the health risk assessment before the visit. His ankle recovered within three weeks of the August visit; he took ibuprofen for four days and is back to about 40 km a week. His depression is in remission on bupropion XL 150 mg with monthly psychotherapy sessions, and his testosterone has been normal since August. The breast tissue is no longer tender. He has had no suicidal thoughts. He has not had HIV or STI testing since moving here and would like it today. He has had one new male partner in the past three months and uses condoms most of the time. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 41 |
| Safety events | No falls, emergency visits, or hospital stays this year |
| Medicines | Bupropion XL 150 mg and cholecalciferol 1,000 units daily; ibuprofen for four days in August |
| Active conditions | Depression in remission; small residual gynecomastia; ankle sprain resolved |
| Sexual health | One new male partner in three months; condoms most of the time; asks for HIV and STI testing |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, much better than in the spring |
| Psychosocial | Sees friends weekly; back with his running club; no current legal proceedings |
| Tobacco | Never used tobacco |
| Alcohol and drugs | Two or three drinks a week (AUDIT-C 2); no drug use |
| Physical activity | Running about 40 km a week with weekly strength work |
| Nutrition | Regular meals; calcium from dairy most days |
| Sleep | About seven hours a night |
| Sexual health | One new male partner in the past three months; condoms most of the time; no symptoms |
| Activities of daily living | Independent |
| Instrumental activities of daily living | Independent |
| Home safety | Smoke detectors working; no firearms in the home |
| Hearing and vision | No concerns |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight steady; no fever or fatigue |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing loss, sore throat, or mouth ulcers |
| Cardiovascular | Negative | No chest pain or palpitations when running |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No abdominal pain, change in bowel habit, or rectal symptoms |
| Genitourinary | Negative | No urethral discharge, dysuria, or genital sores; libido and erections back to his usual |
| Musculoskeletal | Negative | Ankle recovered |
| Integumentary | Negative | No rash or new skin lesions |
| Neurological | Negative | No headaches or numbness |
| Psychiatric | Negative | Mood good; PHQ-9 3 with item 9 scored 0; no suicidal thoughts |
| Breast | Negative | No breast pain, new lump, or nipple discharge |

12 systems reviewed. **S**

## Current medications

- Cholecalciferol 1,000 units (25 mcg) oral tablet, one tablet by mouth daily **S**
- Bupropion extended-release 150 mg oral tablet, one tablet by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/72 mmHg; pulse 54 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 68.5 kg; BMI 21.6 kg/m². All vital signs are synthetic.

PHQ-9: 3; AUDIT-C: 2; Total cholesterol: 182 mg/dL; HDL cholesterol: 62 mg/dL; LDL cholesterol: 104 mg/dL; Triglycerides: 80 mg/dL. All results are synthetic.

## Change since baseline

- PHQ-9: 15 at baseline, 3 at this visit **S**
- AUDIT-C: 2 at baseline, 2 at this visit **S**

## Immunizations given today

- Influenza vaccine, 1953-1954 season **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well and lean; weight 68.5 kg, BMI 21.6 |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm at 54 per minute, as expected in a trained runner; no murmur |
| Respiratory | Clear |
| Breast | Examined with his agreement: a soft disc of glandular tissue about 2 cm behind the left nipple and 1 cm behind the right, non-tender; no discrete mass, skin change, nipple discharge, or axillary nodes |
| Abdomen | Soft and non-tender |
| Genitourinary | Offered and declined today; no symptoms |
| Skin | No rash or suspicious lesions |
| Musculoskeletal | Right ankle stable with full range of motion |
| Mental status | Relaxed, humorous, and engaged; euthymic; no suicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic preventive visit, age 41**. Health risk assessment reviewed and a written prevention plan given. Ten-year cardiovascular risk is under 2 percent by the pooled cohort equations, so a statin is not recommended. Sexual health care offered as routine adult care. **S**
   - HIV, syphilis, hepatitis B and C serology, and urine, pharyngeal, and rectal gonorrhea and chlamydia tests drawn today with his consent; he will be told the results by secure message.
   - PrEP explained: with one partner, condoms most of the time, and no recent STI he does not now meet the indications, and he will tell us if that changes; PrEP is available here whenever it is right for him.
   - Next preventive visit in one year.
2. **Major depressive disorder, single episode, in remission** (F32.1). PHQ-9 3, in remission on bupropion with psychotherapy. Safety reviewed: no suicidal thoughts, intent, or plan; protective factors stronger than at intake. **S**
   - Continue bupropion XL 150 mg for at least six to nine months after remission, then decide together whether to taper.
   - Collaborative safety plan reviewed and unchanged, with the 988 Suicide & Crisis Lifeline and the clinic number.
3. **Residual gynecomastia, improving** (N62). Smaller and non-tender, six months after the estrogen stopped. **S**
   - Watchful waiting; a plastic surgery opinion if it persists about twelve months after the estrogen stopped and he wants it removed.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 116/72 mmHg |
| Cholesterol and statin decision | Completed today | Total cholesterol 182, HDL 62, LDL 104, triglycerides 80 mg/dL; ten-year risk under 2 percent, so no statin; repeat in five years |
| Diabetes screening | Not indicated | BMI 21.6 with no other risk factors; screening is for adults 35 to 70 with overweight or obesity |
| HIV screening | Ordered | HIV antigen and antibody test drawn today with his consent |
| Syphilis, gonorrhea, and chlamydia testing | Ordered | Syphilis serology and urine, pharyngeal, and rectal NAATs by site of exposure, drawn today with his consent; yearly while sexually active, more often if his risk changes |
| Hepatitis C screening | Ordered | One-time antibody test drawn today |
| Hepatitis B screening and vaccination | Ordered | HBsAg, core antibody, and surface antibody drawn today; vaccinate if not immune |
| HIV preexposure prophylaxis | Not indicated | Discussed as routine care; he does not meet the indications now; to be revisited at any visit he wishes |
| Colorectal cancer screening | Not indicated | Begins at 45; no family history recorded |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never used tobacco |
| Depression screening and monitoring | Completed today | PHQ-9 3 in continuation treatment; item 9 scored 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 2 |
| Influenza vaccine, this season | Completed today | Given today with his consent |
| COVID-19 vaccine, this season | Due | Recommended; he will have it at a pharmacy next week |
| Hepatitis A vaccine | Due | Recommended for men who have sex with men; first dose at his next visit after he has thought it over |
| HPV vaccine | Due | Shared decision for adults 27 to 45; he will decide at his next visit |
| Tetanus, diphtheria, and pertussis booster | Up to date | Tdap five years ago |
| Dental examination | Due | No dental visit since moving here; he will book one |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, a close friend, and completed a health care proxy form; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think and work, and that no treatment should ever be given to him without his own agreement or, if he cannot speak, his agent's. He wants full treatment for reversible illness. He asked that his records, including his sexual orientation and the history of the estrogen he was given, be shared only with clinicians treating him. The plan will be revisited yearly. **S**

## Guideline basis

- APA Guidelines for Psychological Practice With Sexual Minority Persons (2021), American Psychological Association
- Sexually Transmitted Infections Treatment Guidelines: Men Who Have Sex with Men (2021), Centers for Disease Control and Prevention
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Results by secure message within a week. COVID-19 vaccine at a pharmacy. Hepatitis A and HPV vaccine decisions at the next visit. Depression review in about two months. Next preventive visit in one year. **S**

